Genome Biology

• 1. Introduction

  ›

  Genome Biology arrived in 2000 with a clear mandate: gather the best peer-reviewed research in genomics and make it openly available to anyone with a connection. At a time when scientific publishing was still largely locked behind subscription paywalls, that open access commitment set the journal apart from the start. BioMed Central, its publisher, built the journal to sit at the center of one of biology's fastest-moving fields. By 2024, the Journal Citation Reports assigned Genome Biology an impact factor of 9.1, a number that reflects how frequently other researchers cite its papers. That figure places it among the more influential outlets in its discipline. The questions worth asking are: what kind of science fills its pages, who shapes its direction, and what does open access actually mean for the way genomic knowledge spreads?

• 2. Open Access and BioMed Central

  ›

  BioMed Central made open access publishing its core model before most scientific publishers took the idea seriously. Genome Biology, launched under that umbrella in 2000, inherited that philosophy from the start. Open access means that a reader in any country, at any institution, can download a paper without paying a subscription fee. For a field like genomics, where data sets and findings build rapidly on one another, removing that barrier has real consequences for how quickly knowledge circulates. BioMed Central's role as publisher also means Genome Biology sits within a network of peer-reviewed journals that share editorial infrastructure and standards. The peer-review process itself is the mechanism by which submitted research is evaluated by other specialists before publication, filtering for rigor and relevance. Veronique van den Berghe took on the role of chief editor in 2022, bringing her oversight to bear on that filtering process.

• 3. Editorial Leadership

  ›

  Veronique van den Berghe became chief editor of Genome Biology in 2022. The chief editor's role in a peer-reviewed journal is to set the intellectual direction of the publication, oversee the handling of submissions, and make final decisions on what gets published. At a journal covering genomics, that means navigating a field that generates enormous volumes of new data and contested interpretations. The impact factor of 9.1 recorded for 2024 by the Journal Citation Reports offers one external measure of the journal's standing under its current and recent leadership. Impact factors are calculated from citation counts, so a score in that range signals that papers published in Genome Biology are being actively referenced by researchers working across the discipline.

• 4. Coverage and Indexing

  ›

  Genome Biology covers research in genomics, the branch of biology concerned with the structure, function, and mapping of genomes. The journal is abstracted and indexed in major databases, which means its papers are catalogued and made searchable through the systems that researchers use to find relevant literature. Indexing is not a minor administrative detail. A journal absent from the major abstracting services is effectively invisible to much of the scientific community. The Journal Citation Reports, which produces the impact factor figures, is itself one of those indexing and tracking systems. The 9.1 impact factor for 2024 is drawn directly from citation data that flows through that infrastructure, making the indexing and the influence measurement part of the same ecosystem.